The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concordance between orthotopic-patient derived xenograft models and patient treatment responses.
 
Jonathan Nakashima
Employment - Certis Oncology Solutions
Stock and Other Ownership Interests - Certis Oncology Solutions
Travel, Accommodations, Expenses - Certis Oncology Solutions
 
Jantzen Sperry
Employment - Certis Oncology Solutions
Stock and Other Ownership Interests - Certis Oncology Solutions
 
Serena Lofftus
No Relationships to Disclose
 
Noah Federman
Stock and Other Ownership Interests - Moderna Therapeutics; Reata Pharmaceuticals
Consulting or Advisory Role - Bayer; Tempus
Speakers' Bureau - Bayer
Research Funding - Mirati Therapeutics
 
Arun S. Singh
Leadership - Certis Oncology Solutions
Stock and Other Ownership Interests - AntiCancer; Certis Oncology Solutions
Honoraria - Galvanize Therapeutics
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Lilly
Speakers' Bureau - AADi; Ayala Pharmaceuticals (Inst); Daiichi Sankyo; Deciphera; Eisai; Lilly; MJH Life Sciences; Novartis; RAIN Therapeutics (Inst); Scripps Health; TRACON Pharma (Inst)
Research Funding - Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); deciphera (Inst); Lilly (Inst); Nanocarrier (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; Eisai; Galvanize Therapeutics; Lilly; Novartis
Other Relationship - Certis Oncology Solutions
 
Frederick C. Eilber
Leadership - Certis Oncology Solutions
Stock and Other Ownership Interests - Certis Oncology Solutions